Pricing Log in Create free account

Akebia Therapeutics, Inc. (AKBA) vs BGM Group Ltd. (BGM)

Akebia Therapeutics, Inc. and BGM Group Ltd. are both Drug Manufacturers Specialty & Generic companies. Akebia Therapeutics, Inc. and BGM Group Ltd. are of similar size ($125.7M and $117.9M). Akebia Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; BGM Group Ltd. trades at 148×. BGM Group Ltd. has the higher net margin (1.96% vs −22.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Akebia Therapeutics, Inc. leads on 7 and BGM Group Ltd. on 7.

Valuation

Metric AKBA BGM Drug Manufacturers Specialty & Generic median
P/E n/m 148.17 20.55
P/S 0.60 n/m 2.08
P/B 5.84 n/m 1.79
Price to free cash flow 8.59 n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 0.05 (0.09) 2.87
Earnings yield (37.21%) 0.67% (15.94%)
Free cash flow yield 11.64% 0.00% 0.00%

Profitability

Metric AKBA BGM Drug Manufacturers Specialty & Generic median
Gross margin 78.90% 6.54% 53.51%
Operating margin (15.74%) 0.00% 0.00%
Net margin (22.60%) 1.96% (2.45%)
Free cash flow margin 7.03% 0.00% 0.00%
Return on equity (143.83%) 0.00% (0.80%)
Return on assets (12.62%) 0.00% (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AKBA BGM Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (12.38%) — 5.22%
EPS growth (last fiscal year) 93.94% 10.00% 42.91%
Revenue growth, 5-year CAGR (4.33%) (5.39%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AKBA BGM Drug Manufacturers Specialty & Generic median
Debt to equity 2.47 0.00 0.04
Current ratio 1.36 1.25 2.41
Net debt to EBITDA (5.51) 0.97 1.01

Dividend

Metric AKBA BGM Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric AKBA BGM Drug Manufacturers Specialty & Generic median
Market cap 117.91m 125.72m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack